Company · CIK 0001516479
Insys Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001564590-20-004232 · 44.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001564590-20-003962 · 1.7 MBSEC(opens sec.gov)
- 8-KCurrent report0001564590-20-003491 · 92.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001564590-20-001346 · 48.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001564590-20-000787 · 853.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001564590-20-000232 · 947.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001564590-19-046971 · 1.8 MBSEC(opens sec.gov)
- 8-KCurrent report0001564590-19-045172 · 2.9 MBSEC(opens sec.gov)
- 8-KCurrent report0001564590-19-043982 · 2.3 MBSEC(opens sec.gov)
- SC 13GInsys Therapeutics, Inc.0001213900-19-024010 · 59.7 KBSEC(opens sec.gov)
Insiders
- Babich Michael LDirector, President and CEO
- BAKER DARRYL SChief Financial Officer
- BOHLEN ELIZABETHDirector
- BRENNAN DANIELExec VP & Chf Operations Off.
- Del Fosse FrancGeneral Counsel
- Dillaha LarryChief Medical Officer
- FOURTEAU PATRICKDirector
- Housley AndreceChief Financial Officer
- Insys Therapeutics, Inc. Voting Trust10% Owner
- KAPOOR JOHN N10% Owner
Tickers
No tickers on record.
Addresses
business
10220 SOUTH 51ST STREET SUITE 2
PHOENIX, AZ, 85044
mailing
10220 SOUTH 51ST STREET SUITE 2
PHOENIX, AZ, 85044
Same industry